• 
• See all for NASDAQ.com News
• View Print Version

• Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points
• Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013
• Techne Corporation (TECH) Ex-Dividend Date Scheduled for May 08, 2013

• AMGN 100% Rate It
• EES 0% Rate It
• GILD 100% Rate It
• PDLI 100% Rate It

PDL BioPharma, Inc. ( PDLI ) has announced an ex-dividend date of December 05, 2012 and a cash dividend payment of $0.15 per share scheduled for December 14, 2012. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 8th quarter that PDLI has paid the same dividend. At the current stock price of $7.9, the dividend yield is 7.59%.

The previous trading day's last sale of PDLI was $7.9, representing a -6.29% decrease from the 52 week high of $8.43 and a 37.15% increase over the 52 week low of $5.76.

PDLI is a part of the Health Care sector, which includes companies such as Amgen Inc. ( AMGN ) and Gilead Sciences, Inc. ( GILD ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.37. Zacks Investment Research reports PDLI's forecasted earnings growth in 2012 as 20.51%, compared to an industry average of 8.5%.

For more information on the declaration, record and payment dates, visit the PDLI Dividend History page.

Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:

• WisdomTree SmallCap Earnings Fund ( EES ).

The top-performing ETF of this group is EES with an increase of 2.11% over the last 100 days. It also has the highest percent weighting of PDLI at 0.61%.

Related Stocks Articles

• 
  Parker Hannifin Reaches 52-Week High - Analyst Blog
  5/21/2013 06:27 PM
• 
  Yahoo to Open Office in Times Square - Analyst Blog
  5/21/2013 06:26 PM
• 
  Positive Data on Novartis' Afinitor - Analyst Blog
  5/21/2013 06:26 PM